Wholesaler News

Aspen Pharmacare Australia Pty Ltd wishes to advise you the price increase of Dymadon Kids Orange 200ml and Dymadon Kids Strawberry 200ml effective as of 1st of February 2021. Please update your records. Download Letter

Aspen Pharmacare Australia Pty Ltd wishes to advise you of product specs change for AP-009239 Lanoxin Amps Infant PAED 5X2ML. Please update your records. Download NPSA Form

Aspen Pharmacare Australia Pty Ltd wishes to advise you of product specs change for AP-012973 Physeptone Injection Vial 10mg/ml x 5. Please update your records. Download NPSA Form

Aspen Pharmacare Australia Pty Ltd wishes to advise you the change of the product code for EMLA PATCH 5% (20 PACK) ASP, while the product EAN and price remain the same. Please update your records. Download Letter Download NPSA Form Please wait a moment for the document to load.

Aspen Pharmacare Australia Pty Ltd wishes to advise you the change of the product code for Dymadon 2-12YRS Strawberry 200ml, while the product EAN and price remain the same. Please update your records. Download Letter Download NPSA Form Please wait a moment for the document to load.

Aspen Pharmacare Australia Pty Ltd wishes to advise you the change of the product code for Xylocaine 5% Ointment tube 35g, while the product EAN and price remain the same. Please update your records. Download Letter Download NPSA Form Please wait a moment for the document to load.

Following on from the notification Aspen sent (dated 27 November 2020), AstraZeneca (AZ) the contracted manufacturer of Aspen’s local anaesthetic agents, has advised the above will be on backorder until the anticipated delivery as listed. At this moment in time, any other Aspen local anaesthetic products not listed above can be ordered as normal. Download…

Aspen is pleased to announce the launch of Slenyto®. Slenyto® is a prolonged-release melatonin therapy that is available in 2 pack sizes: – 1mg x 60 tablets – 5mg x 30 tablets Pharmacies will be advised that Slenyto® will be available to purchase from all wholesalers starting January 1st 2021. In anticipation of orders commencing…

Please be advised effective 1-Jan-2021 distribution responsibilities for Zyprexa, Evista & Evifyne products will revert from Aspen to Eli Lilly Australia. Eli Lilly currently holds, and will remain the marketing authorisation holder for these products. Download Letter

Following on from the notification Aspen sent (dated 30 October 2020), AstraZeneca (AZ) the contracted manufacturer of Aspen’s local anaesthetic agents, has advised the above will be on backorder until the anticipated delivery as listed. At this moment in time, any other Aspen local anaesthetic products not listed above can be ordered as normal. Download…